This interview is with an expert in TAVR/TAVI from Germany. Germany is the largest market in Europe, with over half of TAVR procedures, and a number of devices have recently been approved in Europe, ahead of the US. Hence, the KOL has experience with many of them.

Among other topics, the interview will cover:

• Feedback about specific novel devices
• Selection of valves and outlook for competition based on technology and price
• High volume versus low volume centers
• Expectations for intermediate risk studies, age range likely to be treated, valve-in-valve procedures, and durability of valves
• Usage from registry data in the German market and market expectations
• Feedback on other aspects of the TAVR procedure and trends
• Comparator versus single arm trials

Please also see our 2015 MedDeviceTracker Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Report linked below.

BioMedTracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email BioMedTracker or call BioMedTracker Client Services at (858) 200-2357.